Type of Deal |
Value |
Acquirer |
Target |
Adviser to acquirer (tax) |
Adviser to target (tax) |
Acquisition |
$2 billion |
Advance Auto Parts |
General Parts |
Kirkland & Ellis; Weil Gotshal & Manges; Stikeman Elliott |
Manning Fulton & Skinner PA; Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan |
Acquisition |
Undisclosed |
TripAdvisor |
Oyster Travel Corporation |
Fenwick & West- Ron Schrotenboer |
|
Acquisition |
Undisclosed |
Trafigura; Mubadala Development Company |
MMX Mineracao e Metalicos |
Shearman & Sterling; Stocche Forbes Padis Filizzola |
Davis Polk & Wardwell; Mattos Filho, Veiga Filho, Marrey jr e Quiroga |
Type of Deal |
Value |
Issuer/Borrower |
Lead managers/arrangers |
Adviser to issuer/borrower (tax) |
Adviser to lead managers (tax) |
Revolving credit facility |
$2.5 billion |
Computer Sciences Corporation |
Citibank |
Davis Polk & Wardwell - Michael Mollerus, Ameya Bapat |
Shearman & Sterling |
Initial public offering |
£1 billion |
Infinis |
Barclays; Deutsche Bank; RBC Capital Markets; Liberum Capital; Kempen |
Slaughter and May - Gareth Miles, Michael Ringer; Simpson Thacher & Bartlett |
|
Notes offering |
$500 million |
L Brands |
Merrill Lynch, Pierce, Fenner & Smith, Citigroup Global Markets; JP Morgan Securities |
Davis Polk & Wardwell - Neil Barr, Avinash Venkatesh |
Cahill Gordon & Reindel |
ADS rights offering |
$358 million |
Compania Cervecerias Unidas |
JP Morgan Securities; Citigroup Global Markets; Goldman, Sachs & Co |
Milbank, Tweed, Hadley & McCloy; Claro y Cia |
Davis Polk & Wardwell - Harry Ballan, Michael Farber |
Follow-on offering |
$120 million |
KYTHERA Biopharmaceuticals |
JP Morgan Securitiesl; Merrill Lynch, Pierce, Fenner & Smith |
Latham & Watkins |
Davis Polk & Wardwell - Rachel Kleinberg, Catherine Paskoff Chang |
Common stock offering |
$90 million |
Cumulus Media |
RBC Capital Markets |
Jones Day |
Davis Polk & Wardwell - Samuel Dimon, Juelle Gomes |
